Bumper crop of new drugs fails to lift big pharma Research and Development returns Ruby Khatun Khatun16 Dec 2017 9:45 AM ISTLONDON: It is shaping up to be a bumper year for drug approvals, with U.S. officials clearing twice as many novel medicines as in 2016, yet returns on...
FDA approves Novo Nordisk diabetes drug Ozempic Ruby Khatun Khatun6 Dec 2017 10:30 AM ISTThe U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
Survey claims 59 percent people depend track medical symptoms on apps Ruby Khatun Khatun4 Dec 2017 10:15 AM ISTMumbai: Healthcare apps are rapidly gaining popularity in the country with almost 59 percent of the people's usage increasing over the past year to...
Roche Diabetes Care eyes 51 percent market share in India by 2019 Ruby Khatun Khatun27 Nov 2017 10:18 AM ISTNew Delhi: Roche Diabetes Care India is aiming to have up to 51 percent market share in blood glucose monitoring segment in the country by the end of...
Virinchi Hospitals partners with MedGenome to offer Molecular diagnostics Ruby Khatun Khatun24 Nov 2017 10:17 AM ISTHyderabad: Virinchi Hospitals, a subsidiary of Hyderabad-based IT company Virinch Limited has partnered with MedGenome, a genomics-based diagnostics...
Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs Ruby Khatun Khatun24 Nov 2017 9:30 AM ISTDenmark: Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for its...
Novo Nordisk partners with Karnataka State Government Employees Association for Diabetes screening and awareness Ruby Khatun Khatun18 Nov 2017 9:48 AM ISTBENGALURU: Novo Nordisk, a global healthcare company with more than 90 years of innovation and leadership in diabetes care organized a diabetes...
Zydus gets regulatory nod to market Lipaglyn in Mexico Ruby Khatun Khatun11 Nov 2017 10:32 AM ISTNew Delhi: Drug firm Zydus said it has received approval from the Mexican regulatory authority to market Lipaglyn (Saroglitazar Magnesium) used for...
VPS Healthcare sets aside Rs 1,000 crore for investing in Indian Hospital Space Ruby Khatun Khatun20 Oct 2017 10:35 AM ISTMUMBAI: The son-in-law of the Lulu Group founder MA Yusuf Ali and founder of VPS Healthcare Group, Dr Shamsheer Vayalil, is reported to have created a...
Eris Lifesciences acquires UTH Healthcare for Rs 12.85 crore Ruby Khatun Khatun5 Oct 2017 2:39 PM ISTNew Delhi: Eris Lifesciences said it has acquired nutraceuticals maker UTH Healthcare for Rs 12.85 crore.UTH Healthcare is largely present in obesity,...
Zydus gets USFDA nod to market anti-diuretic nasal spray Ruby Khatun Khatun5 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
FDA approves Novo Nordisk fast-acting insulin Fiasp Ruby Khatun Khatun4 Oct 2017 9:57 AM ISTThe U.S. Food and Drug Administration (FDA) on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.The product, known as Fiasp, is...
